Clinical Trials Archives - Proventa International

Revvity – AI with Purpose: Strategy-First Innovation Across Clinical Trials

Bryan — Mon, 23 Mar 2026 21:01:45 +0000

19
May

06:00 PM EDT

AI with Purpose: Strategy-First Innovation Across Clinical Trials

Ocean Prime 140 Seaport Blvd, Boston

Fully Booked

What to expect

Timely information, interactive format

Join a select group of senior clinical executives in Boston for an intimate, invitation-only dinner focused on the next evolution of clinical oversight: moving from fragmented review and reactive issue management to governed, strategy-first, AI-augmented oversight.

This executive discussion will examine how sponsors and CROs can operationalize AI in ways that are transparent, traceable, and firmly human-directed. Glenn Guthrie and Chris Macri will serve as co-moderators for the opening introduction, framing the evening around practical adoption, organizational readiness, and decision-making that can withstand regulatory scrutiny.

Amanda Cross will lead Roundtable I, “What Does Oversight Look Like?”, bringing an advisory perspective grounded in biometrics operations, clinical data governance, risk, and accountability. Michelle Fisher, Director, Clinical Data Management at Hemab Therapeutics, will lead Roundtable II, “AI with Purpose Starts with the Patient: Patient Centricity in Clinical Data Management,” connecting AI innovation to the realities of study execution, data quality, and the patient experience.

Attendance is intentionally limited to approximately 20 senior leaders to support candid peer
exchange and actionable discussion.

Our Agenda

18:40 – 19:10

What Does Oversight Look Like?

Led by Amanda Cross Biometrics & Clinical Data Advisory Risk, Integration, Oversight & Governance

19:20 – 19:40

AI with Purpose Starts with the Patient

Led by Michelle Fisher Director, Clinical Data Management, Hemab Therapeutics

At this dinner you’ll

This exclusive, invitation-only Revvity Strategy Dinner in Boston brings together senior clinical leaders for an intimate, thought-provoking evening of dialogue and collaboration focused on the future of clinical oversight and data-driven decision-making. The event is designed to help you explore practical strategies for transforming how clinical data is reviewed, governed, and leveraged across increasingly complex trials. -Gain strategic insights on clinical data science — Understand how near-real-time analytics and governed review processes can elevate study performance, quality, and patient safety. -Explore AI-augmented oversight best practices — Learn how to deploy AI with guardrails that support traceability, audit-readiness, and regulatory compliance. -Benchmark against your peers — Engage in candid roundtable discussions with senior executives from the Greater Boston biotech and pharma ecosystem to compare approaches, challenges, and solutions. -Connect in a high-value setting — Build meaningful professional relationships over dinner in a relaxed, collaborative environment. Discuss real business priorities — From CRO oversight maturity to organizational change management, the conversation is focused on real-world strategies that can drive measurable impact across clinical operations. Whether you’re leading data strategies, clinical operations, or innovative governance models, this dinner offers a unique opportunity to align with forward-thinking peers and spark actionable ideas for your organization’s next phase of data-driven growth.

Meet Our Facilitators

Amanda Cross

Biometrics & Clinical Data Advisory Risk, Integration, Oversight & Governance

Michelle Fisher

Director, Clinical Data Management Hemab Therapeutics

Glenn Guthrie

Senior Principal Clinical Solutions Strategy Revvity Signals

First name	Last name	Job title	Company name	Photo URL	Bio Position
Amanda	Cross	Biometrics & Clinical Data Advisory	Risk, Integration, Oversight & Governance	https://proventainternational.com/wp-content/uploads/2026/04/Amanda-Cross.jpg
Michelle	Fisher	Director, Clinical Data Management	Hemab Therapeutics	https://proventainternational.com/wp-content/uploads/2026/04/Michelle-Fisher.jpg
Glenn	Guthrie	Senior Principal Clinical Solutions Strategy	Revvity Signals	https://proventainternational.com/wp-content/uploads/2025/11/3a8daac2-0bdd-47f0-b82f-1845cb5def59_thumb.jpg	With 18 years of experience developing medical and health-based visualizations and analytics, Glenn is a thought leader in oncology analytics and clinical data review. He has led technical engagements across small, mid, and large pharma, delivering Spotfire-powered clinical solutions that enhance oversight, pharmacovigilance, and operational workflows. His background spans neural networks, enterprise informatics, and customer-centric solution architecture.

More about Revvity

More information

Revvity Signals Software offers one of the most comprehensive arrays of scientific software in the world. Our powerful informatics solutions are used across Pharma and Biotech to support the complex demands of modern research and development. Clinical trials generate vast volumes of critical data, yet transforming that data into timely, actionable insight remains a challenge for many organizations. Revvity Signals Clinical, powered by global analytics leader Spotfire®, is a clinical data science solution that enables near realtime insight delivery to enhance study data quality, patient safety, and operational performance. The platform supports clinical data review, medical review, clinical operations, risk-based monitoring, and pharmacovigilance workflows within a governed, collaborative environment. No scientific software company offers a broader or more powerful range of informatics solutions than Revvity Signals Software.

Further Information

Interested in attending this virtual roundtable or running your own? Drop us a message today and we will get in touch

Here To Help

Need help registering your team? Just get in touch and a member of the team will be happy to help.

[contact-form-7]

The post Revvity – AI with Purpose: Strategy-First Innovation Across Clinical Trials appeared first on Proventa International.

Revvity – No One Has Enough Data: Building the Federated Ecosystem for Next-Generation Drug Discovery

Bryan — Mon, 23 Mar 2026 15:26:18 +0000

13
May

06:00 PM PDT

No One Has Enough Data: Building the Federated Ecosystem
for Next-Generation Drug Discovery

STK Steakhouse San Diego

Fully Booked

What to expect

Timely information, interactive format

Despite unprecedented advances in AI and computational sciences, the pace and cost of bringing new therapies to patients remain stubbornly high. One fundamental constraint is increasingly clear: no single organization possesses sufficient data diversity, scale, or longitudinal depth to fully model the behavior of drug modalities.

Federated learning offers a path forward. By enabling models to be trained across institutions without exposing sensitive data, organizations can collaborate while preserving intellectual property, regulatory compliance, and competitive advantage. Yet technology alone is not enough. Real progress requires new governance models, incentive structures, partnerships, and cultural shifts across the biopharmaceutical ecosystem. This strategy dinner convenes Drug Discovery leaders who have a deep understanding of the importance of data and how to leverage technology to maximize their potential.

Topics include privacy-preserving computation, trusted data infrastructure, precompetitive collaboration models, and the operational realities of cross-organizational AI. Together, participants will examine whether federated approaches can meaningfully reduce the traditional 10-year, multi-billion-dollar path to drug development — and what it will take to move from isolated innovation to collective intelligence.

Our Agenda

19:30 – 20:30

Roundtable Tracks

21:30 – 22:30

Roundtable Tracks

Why you should attend

This exclusive Strategy Dinner is designed for senior leaders and strategic decision-makers at the forefront of drug discovery, data science, and pharmaceutical innovation. It brings together a carefully curated group of executives, technical leaders, and thought partners from across the life sciences ecosystem who are shaping the future of cross-organization collaboration and data-driven R&D.
Ideal attendees include:
Heads of Drug Discovery & Preclinical Development
Leaders responsible for steering discovery pipelines, adopting next-generation technologies, and breaking down barriers to accelerate candidate selection.
Data Strategy, AI/ML & Informatics Leaders
Senior professionals tasked with architecting data ecosystems, implementing advanced analytics, and scaling federated or cross-enterprise AI initiatives.
R&D and Technology Executives
Directors and VPs overseeing digital transformation, scientific innovation, and the integration of computational platforms across complex R&D workflows.
Strategic Collaborators & Innovation Partners
Decision-makers from biotech, pharma, and research institutions who are exploring precompetitive models, federated data frameworks, and novel governance structures to drive collective impact.
Thought Leaders in Scientific Software & Analytics
Experts focused on the intersection of technology, science, and operational execution, including leaders who influence tool adoption and digital strategy at an organizational level.
Attendance is limited to ensure meaningful, high-value dialogue in an intimate roundtable format, enabling participants to share actionable insights, benchmark strategies, and build long-lasting professional connections.

Meet Our Facilitators

David Gosalvez, Ph.D

Chief Strategy Officer-Signals Revvity Signals Software

With 25 years of experience in scientific software and analytics, David Gosalvez brings a rare combination of technical and domain expertise with broad knowledge across scientific use cases. He is a passionate advocate for improving the efficiency and quality of science via innovative software solutions. As head of Product Strategy, David works with scientists and IT across pharma and chemical industry to set the direction of the Revvity Signals Informatics portfolio. He also works with other scientific software vendors to integrate complimentary capabilities and AI/ML models into our solutions. As Director of Cheminformatics, he was responsible for the sustained growth of ChemDraw and Spotfire Lead Discovery. Previously, David headed the interdisciplinary Science & Technology team chartered with creating the novel data management technologies that underpinned Revvity Signals platform. David also served as Executive Director of Application Development at CambridgeSoft where he brought to market the Oracle Chemistry Cartridge and ChemBioOffice Enterprise Suite.

Gregg Spivey

Executive Director, AI/ML Partnerships Eli Lilly and Company

External	Id	First name	Middle name	Last name	Honorific	Job title	Company name	Photo URL	Bio Position
		David		Gosalvez, Ph.D		Chief Strategy Officer-Signals	Revvity Signals Software	https://proventainternational.com/wp-content/uploads/2025/04/David-Gosalvez-1.jpg	With 25 years of experience in scientific software and analytics, David Gosalvez brings a rare combination of technical and domain expertise with broad knowledge across scientific use cases. He is a passionate advocate for improving the efficiency and quality of science via innovative software solutions. As head of Product Strategy, David works with scientists and IT across pharma and chemical industry to set the direction of the Revvity Signals Informatics portfolio. He also works with other scientific software vendors to integrate complimentary capabilities and AI/ML models into our solutions. As Director of Cheminformatics, he was responsible for the sustained growth of ChemDraw and Spotfire Lead Discovery. Previously, David headed the interdisciplinary Science & Technology team chartered with creating the novel data management technologies that underpinned Revvity Signals platform. David also served as Executive Director of Application Development at CambridgeSoft where he brought to market the Oracle Chemistry Cartridge and ChemBioOffice Enterprise Suite.
		Gregg		Spivey		Executive Director, AI/ML Partnerships	Eli Lilly and Company	https://proventainternational.com/wp-content/uploads/2026/03/Gregg-Spivey.jpg	Gregg’s role at Lilly focuses on how we can best collaborate with a wide range of partners to combine our resources and expertise to advance the next generation of AI/ML models and tools to help improve drug discovery. As a key part of this, Gregg was part of the founding team behind Lilly TuneLab: a collaborative platform created to offer Biotechs access to AI/ML tools leveraging Lilly’s own drug discovery models, and then to continuously improve these models via federated learning across data sourced from the ecosystem of TuneLab member companies. Prior to Lilly, Gregg spent 10+ years operating in cross-functional teams delivering impactful ML/AI powered solutions across Drug Discovery, Biotech, Digital Health, and Tech; at varying scales from startups up to Apple iOS feature releases.

David Gosalvez, Ph.D, Gregg Spivey

More about Revvity

More information

Revvity Signals Software delivers AI-powered solutions accelerating R&D and enabling data-driven innovation. Signals One, our flagship solution, streamlines R&D workflows with data capture, collaboration, data processing, and data-driven analytics. It includes i Signals Notebook, the only cloud-native electronic lab notebook with ChemDraw®, Spotfire® powered advanced analytics, as well as next-gen data management. Also new solutions include Signals BioDesign for Molecular cloning and Signals Synergy for CRO collaboration. Trusted by pharma and biotech, our portfolio empowers scientists with predictive analytics, seamless collaboration, and interactive visualizations for breakthrough discoveries.

Further Information

Interested in attending this virtual roundtable or running your own? Drop us a message today and we will get in touch

Here To Help

Need help registering your team? Just get in touch and a member of the team will be happy to help.

[contact-form-7]

The post Revvity – No One Has Enough Data: Building the Federated Ecosystem for Next-Generation Drug Discovery appeared first on Proventa International.

Revvity – AI with Purpose: Strategy-First Innovation Across Clinical Trials San Francisco 2025

Bryan — Mon, 22 Sep 2025 18:13:28 +0000

13
November

05:15 PM PST

AI with Purpose: Strategy-First Innovation Across Clinical Trials

STK Steakhouse San Francisco

Fully Booked

What to expect

Timely information, interactive format

An Exclusive Executive Roundtable for Bay Area Clinical Leaders.

Join a private dinner at STK Steakhouse with a select group of peers for a candid discussion on elevating trial oversight from reactive issue management to proactive, analytics-driven governance.

The evening will showcase real-world perspectives from across the industry and explore pragmatic strategies for embedding AI and augmented analytics into safety and data review. The conversation is designed to surface actionable insights that can accelerate timelines, strengthen CRO partnerships, and build a culture of data-driven decision-making.

Attendance is strictly limited to ensure meaningful dialogue and connections among senior leaders shaping the future of clinical trials.

Our Agenda

18:30 – 19:30

Oversight, AI, and the Future of Clinical Trials

20:30 – 21:30

Building a Data-Driven Culture that Accelerates Clinical Trials

Why you should attend

TOPICS INCLUDE:
• CRO Oversight Maturity – Moving beyond vendor management to proactive governance powered by data and analytics
• Data-Driven Trial Culture – Embedding traceability, audit-readiness, and continuous oversight into study operations
• AI with Purpose – Practical applications that accelerate query cycles, safety reviews, and confident decision-making
• Next-Gen Capabilities – Preview of assistive AI tools like automated clinical listing generation to streamline data review

Meet Our Facilitators

Bill Goode, MS

Founder, Life Sciences Technology Consultant Involve Data Inc.

Tonya Arthur

Head of Data Operations

Brent Meyers, MBA

Director of Product Portfolio Revvity Signals Clinical

First name	Last name	Job title	Company name	Photo URL	Bio Position
Bill	Goode, MS	Founder, Life Sciences Technology Consultant	Involve Data Inc.	https://proventainternational.com/wp-content/uploads/2025/09/Bill-Goode.jpg	Bill Goode is the Founder of a life sciences technology consultancy that partners with leading biopharma organizations to drive transformational change. With deep expertise in data and IT strategies across research and clinical domains, he helps teams improve efficiency, accelerate outcomes, and ultimately better serve patients. Passionate about high-performing teams and innovation, Bill brings a unique perspective at the intersection of science, technology, and clinical development.
Tonya	Arthur	Head of Data Operations		https://proventainternational.com/wp-content/uploads/2025/09/Tonya-Arthur.jpg	Tonya Arthur is a seasoned operations leader with deep expertise in biometrics, data analytics, and quality risk management. She has a proven record of building collaborative, high-performing teams, driving process improvements, and elevating vendor partnerships across clinical trials. Tonya combines her background in clinical research and nursing with a people- centered leadership style that fosters loyalty, strengthens retention, and delivers sustainable results.
Brent	Meyers, MBA	Director of Product Portfolio	Revvity Signals Clinical	https://proventainternational.com/wp-content/uploads/2025/09/Brent-Meyers.jpg	Brent Meyers has over 22 years of experience building analytics solutions and leading technical delivery teams across life sciences and beyond. At Revvity Signals, he directs the Clinical product portfolio, driving innovation in data review, clinical operations, and pharmacovigilance. Previously, Brent led the design of advanced analytics solutions at IQVIA and PPD, built systems for Northrop Grumman, and served as a U.S. Navy officer. He holds a BA from The Citadel and an MBA from Meredith College.

Bill Goode, MS, Tonya Arthur, Brent Meyers, MBA

More about Revvity

More information

Revvity Signals Software is dedicated to helping life sciences organizations transform complex data into actionable insights. In clinical research, this means delivering the analytics power needed to turn vast amounts of trial data into better decisions—where powerful analytics meet better clinical outcomes. Signals Clinical, powered by Spotfire®, is an end-to-end clinical data science solution that streamlines data review and medical monitoring. As the exclusive Spotfire partner in clinical research, it uniquely combines prebuilt clinical visualizations, standardized views across single and pooled studies, and the flexibility to build study-specific dashboards. With near real-time insights, study teams can improve data quality, strengthen patient safety, and optimize trial operations—helping clinical researchers move faster and smarter.

Further Information

Interested in attending this virtual roundtable or running your own? Drop us a message today and we will get in touch

Here To Help

Need help registering your team? Just get in touch and a member of the team will be happy to help.

[contact-form-7]

The post Revvity – AI with Purpose: Strategy-First Innovation Across Clinical Trials San Francisco 2025 appeared first on Proventa International.

Revvity – AI with Purpose: Strategy-First Innovation Across Drug Discovery 2025

Mary Joy Nuevo — Fri, 19 Sep 2025 13:38:47 +0000

19
November

05:15 PM EST

AI with Purpose: Strategy-First Innovation Across Drug Discovery

Boston Chops Downtown

What to expect

Timely information, interactive format

As therapeutic pipelines grow in complexity, many organizations struggle to deploy AI/ML meaningfully across early R&D. Challenges include fragmented data ecosystems, siloed teams, and difficulty scaling models across modalities. This dinner roundtable brings together senior discovery and data leaders to explore how to implement AI strategies that scale, align with FAIR principles, and accelerate decision-making across small molecules, biologics, and new modalities. The discussion will highlight actionable strategies for unifying chemical and biological data, enhancing model reliability, and fostering cross-functional buy-in for digital transformation.

Our Agenda

18:30 – 19:30

Solving AI-Driven Discovery at Scale – From Concept to Clinical Candidate

20:30 – 21:30

Roundtable Tracks

21:30 – 22:30

Designing FAIR-Centric Data Platforms for the Future of Multimodal R&D

Why you should attend

TOPICS INCLUDE:
• AI & ML implementation in drug discovery workflows
• Data interoperability across therapeutic areas and modalities
• FAIR data practices to enable reusability and collaboration
• Platform strategies that bridge chemistry and biology

Meet Our Facilitators

David Gosalvez, Ph.D

Chief Strategy Officer-Signals Revvity Signals Software

Dr. Anastasia Christianson

Life Science Senior Consultant and Strategic Adviser Former SVP and Head of AI, Data, and Analytics Pfizer

External	Id	First name	Middle name	Last name	Honorific	Job title	Company name	Photo URL	Bio Position
		David		Gosalvez, Ph.D		Chief Strategy Officer-Signals	Revvity Signals Software	https://proventainternational.com/wp-content/uploads/2025/04/David-Gosalvez-1.jpg	With 25 years of experience in scientific software and analytics, David Gosalvez brings a rare combination of technical and domain expertise with broad knowledge across scientific use cases. He is a passionate advocate for improving the efficiency and quality of science via innovative software solutions. As head of Product Strategy, David works with scientists and IT across pharma and chemical industry to set the direction of the Revvity Signals Informatics portfolio. He also works with other scientific software vendors to integrate complimentary capabilities and AI/ML models into our solutions. As Director of Cheminformatics, he was responsible for the sustained growth of ChemDraw and Spotfire Lead Discovery. Previously, David headed the interdisciplinary Science & Technology team chartered with creating the novel data management technologies that underpinned Revvity Signals platform. David also served as Executive Director of Application Development at CambridgeSoft where he brought to market the Oracle Chemistry Cartridge and ChemBioOffice Enterprise Suite.
		Dr.		Anastasia Christianson		Life Science Senior Consultant and Strategic Adviser Former SVP and Head of AI, Data, and Analytics	Pfizer	https://proventainternational.com/wp-content/uploads/2025/04/Dr.-Anastasia-Christianson.jpg	Dr. Christianson, a Pharmaceutical AI & Data Science Pioneer, brings nearly three decades of pharmaceutical industry transformation as former SVP and Global Head of AI at Pfizer and leader at J&J, BMS, and AstraZeneca. Her unparalleled expertise spans: • Strategic AI Implementation that delivers measurable business value • Global AI Policy Leadership through White House and National Academy of Medicine engagements • Cross-Industry Innovation as advisor to biotech startups, venture capital, and global health initiatives

David Gosalvez, Ph.D, Dr. Anastasia Christianson

More about Revvity

More information

Revvity Signals Software provides an extensive range of scientific solutions, empowering researchers and pharmaceutical pioneers worldwide. Our cutting-edge technology simplifies processes, speeds up experiments, and prioritizes promising compounds, redefining drug discovery. The Signals Research Suite, our flagship solution, streamlines R&D workflows with data capture, collaboration, data processing, and data-driven analytics. It includes i Signals Notebook, the only cloud-native electronic lab notebook with ChemDraw®, Spotfire® powered advanced analytics, as well as next-gen data management. In addition, we have recently introduced Signals Synergy which is designed to substantially enhance collaboration, project management, and data exchange between sponsors and CROs.

Further Information

Interested in attending this virtual roundtable or running your own? Drop us a message today and we will get in touch

Here To Help

Need help registering your team? Just get in touch and a member of the team will be happy to help.

[contact-form-7]

The post Revvity – AI with Purpose: Strategy-First Innovation Across Drug Discovery 2025 appeared first on Proventa International.

IQVIA Technologies: Join the Journey 2024

Bryan — Mon, 23 Sep 2024 15:50:07 +0000

14
November

06:00 PM CEST

IQVIA Technologies: Join the Journey

Boston Chops Downtown, Boston, MA 02111

What to expect

Timely information, interactive format

Relax after a long day and enjoy and evening of drinks, dinner and stimulating roundtable conversation about how technology is shaping the landscape of clinical research.
• Get to know IQVIA clinical technology leaders and our guests
• Exchange ideas on leveraging technology for efficiency gains
• Share success stories and lessons learned among your peers

Our Agenda

Why you should attend

At IQVIA Technologies, we invite you to not just witness but actively participate in envisioning the future. Hear the visionary perspectives, and embark on this transformative journey with us. Join the conversation. Join the movement. Join IQVIA Technologies. Hear the vision. Join the journey.

Meet Our Facilitator

Michael Klenrock

Senior Research Director, IQVIA Institute for Human Data Science IQVIA

Naouel Baili

Director, AI Scientist IQVIA Technologies

Helen Greta

Director, Project Management Digital Products & Solutions, Patient Delivery IQVIA

First name	Last name	Job title	Company name	Photo URL	Bio Position
Michael	Klenrock	Senior Research Director, IQVIA Institute for Human Data Science	IQVIA	https://proventainternational.com/wp-content/uploads/2024/09/Michael-Kleinrock.jpg	Michael Kleinrock serves as Research Director for the IQVIA Institute for Human Data Science, setting the research agenda for the Institute, leading the development of reports and projects focused on the current and future role of human data science in healthcare in the United States and globally. Kleinrock leads the research development included in Institute reports published throughout the year. The research is focused on advancing the understanding of healthcare and the complex systems and markets around the world that deliver it. Throughout his tenure at IMS Health, which began in 1999, he has held roles in customer service, marketing, product management, and in 2006 joined the Market Insights team, which is now the IQVIA Institute for Human Data Science. He holds a B.A. degree in History and Political Science from the University of Essex, Colchester, UK, and an M.A. in Journalism and Radio Production from Goldsmiths College, University of London, UK.
Naouel	Baili	Director, AI Scientist	IQVIA Technologies	https://proventainternational.com/wp-content/uploads/2024/04/Naouel-Baili.jpg	Naouel is an expert in emerging technology solutions, leveraging over ten years of experience in the life sciences industry to transform clinical trial management. Her proficiency in embedding sophisticated AI tools into SaaS platforms has significantly improved both user experience and operational efficiency. A holder of a Ph.D. in Computer Science, she excels in the development and design of innovative AI capabilities that streamline and optimize clinical research.
Helen	Greta	Director, Project Management Digital Products & Solutions, Patient Delivery	IQVIA	https://proventainternational.com/wp-content/uploads/2024/08/Helen-Greta.jpg	Helen brings over 19 years of deep expertise from the clinical research industry and significant global experience working with various CROs, supporting clinical operations teams across, Asia, Middle East, Europe and US. Her expertise includes Clinical monitoring, Project management, Regulatory affairs, and Clinical technologies such as IRT and eCOA. Helen has been a part of IQVIA and the IQVIA IRT leadership team since 2015. She has recently taken on responsibility as Complete Consent IRT eCOA customer success lead and supporting North America Project Management team at IQVIA IRT. Prior to her stint at IQVIA, Helen held several positions across various global CROs. Helen is based out of IQVIA headquarters in Durham, North Carolina.

Michael Klenrock, Naouel Baili, Helen Greta

More about IQVIA

More information

IQVIA Clinical Technologies develops and delivers clinical trial software products providing sponsors, sites, and CROs with an operational advantage to transform the trial experience for sites and patients. We apply our expertise in healthcare- grade AI to gain efficiencies and insights in trial planning and budgeting, sponsor- site communication, patient engagement, and sponsor oversight. Our market-leading SaaS products and tech- enabled services are offered independently from our CRO services to match any business model. Explore our full line of orchestrated clinical trial technologies at iqvia.com/oct and contact us to learn more.

Further Information

Interested in attending this virtual roundtable or running your own? Drop us a message today and we will get in touch

Here To Help

Need help registering your team? Just get in touch and a member of the team will be happy to help.

[contact-form-7]

The post IQVIA Technologies: Join the Journey 2024 appeared first on Proventa International.

IQVIA – Innovation Day at Scope Europe 2024

Bryan — Mon, 22 Jul 2024 18:14:59 +0000

28
October

02:30 PM CEST

IQVIA Innovation Day at Scope Europe 2024

InterContinental Ambassador ® Barcelona Spain

Registration Close

What to expect

Timely information, interactive format

Clinical trial sponsors are invited to join IQVIA Technologies’ digital product leaders and industry representatives for an afternoon of discussions, demos, and networking. IQVIA will share our vision to transform clinical operations and ask for your input on our roadmap for future product development.

Stay on for SCOPE Europe and attend IQVIA sessions there as well.

Innovation Day will be of interest to pharmaceutical executives with various roles in clinical operations, innovation, technology, finance or budgeting, data analytics or strategy, strategic sourcing, trial managers, medical directors, business operations, patient or site engagement.

Our Agenda

Kevin Landells
VP, Patient Centered Technology Delivery
IQVIA Technologies

Bernd Haas
SVP, Digital Product & Solutions
IQVIA

Moderator: Gareth Dabbs,
Vice President, Product Strategy DP&S,
IQVIA

Bernhard Glombitza,
Vice President & Head of Clinical Operations and
Customer Engagement EMEA/LATAM,
Bayer

Marisa Minetti,
Patient Research Partner,
Chiesi Group

Raphaelle Gilg,
SSO Strategy and Operation Manager EMEA,
Novartis

Chloe Rose,
Executive Director, Portfolio Management,
Pratia

Alison Liddy,
Senior VP, Patient and Site Centric Solutions,
IQVIA

Moderator: Kevin Landells,
VP, Patient Centered Technology Delivery,
IQVIA Technologies

Petar Genov,
Senior Director, Business Operations and Capabilities,
IQVIA Technologies

Adrian Kizewski,
Associate Director, Clinical Technology,
IQVIA Technologies

Stefan Dürr,
Senior Director, Client Delivery,
IQVIA Technologies

Chris Burke,
Global Head, Solution Engineering,
IQVIA

Kevin Landells
VP, Patient Centered Technology Delivery
IQVIA Technologies

Why you should attend

Meet Our Facilitator

Chris Burke

Global Head, Solution Engineering IQVIA Technologies

Gareth Dabbs

Vice President, Product Strategy DP&S IQVIA

Stefan Dürr

Senior Director, Client Delivery IQVIA Technologies

Petar Genov

Senior Director, Business Operations and Capabilities IQVIA Technologies

Raphaelle Gilg

SSO Strategy and Operation Manager EMEA Novartis

Bernhard Glombitza

Vice President & Head of Clinical Operations and Customer Engagement EMEA/LATAM Bayer

Kate Godwin-Smith

Director, Solution Engineering IQVIA Technologies

Bernd Haas

SVP, Digital Product & Solutions IQVIA

Adrian Kizewski

Associate Director, Clinical Technology RBQM Technology IQVIA

Kevin Landells

Vice President, Business Head for IRT IQVIA Technologies

Alison Liddy

Senior VP, Patient and Site Centric Solutions IQVIA

Marisa Minetti

Patient Research Partner Chiesi Group

Lorenzo Parma

Director, Solution Engineering IQVIA Technologies

Dan Pavitt

Director, Solution Engineering IQVIA

Chloe Rose

Executive Director, Portfolio Management Pratia

Jack Tranter

Director, Clinical Technology Solutions, IQVIA Clinical Technologies IQVIA Technologies

Francesco D’Agostino

Director, Tech Solution Sales IQVIA Technologies

First name	Last name	Job title	Company name	Photo URL	Bio Position
Chris	Burke	Global Head, Solution Engineering	IQVIA Technologies	https://proventainternational.com/wp-content/uploads/2023/08/Chris-Burke-1.jpg
Gareth	Dabbs	Vice President, Product Strategy DP&S	IQVIA	https://proventainternational.com/wp-content/uploads/2024/10/Gareth-Dabbs.jpg
Stefan	Dürr	Senior Director, Client Delivery	IQVIA Technologies	https://proventainternational.com/wp-content/uploads/2024/07/Stefan-Durr.jpg
Petar	Genov	Senior Director, Business Operations and Capabilities	IQVIA Technologies	https://proventainternational.com/wp-content/uploads/2024/07/Petar-Genov.jpg
Raphaelle	Gilg	SSO Strategy and Operation Manager EMEA	Novartis	https://proventainternational.com/wp-content/uploads/2024/10/Raphaelle-Gilg.jpg
Bernhard	Glombitza	Vice President & Head of Clinical Operations and Customer Engagement EMEA/LATAM	Bayer	https://proventainternational.com/wp-content/uploads/2024/10/Bernhard-Glombitza.jpg
Kate	Godwin-Smith	Director, Solution Engineering	IQVIA Technologies	https://proventainternational.com/wp-content/uploads/2022/09/Kate-Godwin.jpg
Bernd	Haas	SVP, Digital Product & Solutions	IQVIA	https://proventainternational.com/wp-content/uploads/2024/10/Bernd-Haas.jpg
Adrian	Kizewski	Associate Director, Clinical Technology	RBQM Technology IQVIA	https://proventainternational.com/wp-content/uploads/2022/11/Adrian-Kizewski.jpg	Adrian brings expertise spanning R&D and clinical life sciences, business analysis, process design & improvement, and product implementation. Adrian holds an MBA from the McDonough School of Business at Georgetown University in addition to an MSc in Pharmacology from The Johns Hopkins University School of Medicine and a BSc in Biochemistry from Temple University.
Kevin Landells		Vice President, Business Head for IRT	IQVIA Technologies	https://proventainternational.com/wp-content/uploads/2023/08/Kevin-Landells.jpg	Kevin has over 25 years of experience in the IRT/ RTSM industry, having worked across many technical and project management leadership roles. Experienced with developing and leading global teams delivering managed services spanning operations, project management, client partnerships and Business transformation. Kevin is passionate about improving healthcare and utilizing technology that makes a real difference to patients’ lives. Kevin holds a Bachelors’ Degree in Computer Science from Hertfordshire University in the UK.
Alison	Liddy	Senior VP, Patient and Site Centric Solutions	IQVIA	https://proventainternational.com/wp-content/uploads/2024/10/Alison-Liddy.jpg
Marisa	Minetti	Patient Research Partner	Chiesi Group	https://proventainternational.com/wp-content/uploads/2024/10/Marisa-Minetti.jpg
Lorenzo Parma		Director, Solution Engineering	IQVIA Technologies	https://proventainternational.com/wp-content/uploads/2024/07/Lorenzo-Parma.jpg
Dan Pavitt		Director, Solution Engineering	IQVIA	https://proventainternational.com/wp-content/uploads/2023/08/Dan-Pavitt.jpg
Chloe	Rose	Executive Director, Portfolio Management	Pratia	https://proventainternational.com/wp-content/uploads/2024/10/Chloe-Rose.jpg
Jack	Tranter	Director, Clinical Technology Solutions, IQVIA Clinical Technologies	IQVIA Technologies	https://proventainternational.com/wp-content/uploads/2024/10/Jack-Tranter.jpg
Francesco	D’Agostino	Director, Tech Solution Sales	IQVIA Technologies	https://proventainternational.com/wp-content/uploads/2024/10/Francesco-DAgostino.jpg

Chris Burke, Gareth Dabbs, Stefan Dürr, Petar Genov, Raphaelle Gilg, Bernhard Glombitza, Kate Godwin-Smith, Bernd Haas, Adrian Kizewski, Kevin Landells, Alison Liddy, Marisa Minetti, Lorenzo Parma, Dan Pavitt, Chloe Rose, Jack Tranter, Francesco D’Agostino

More about IQVIA

More information

IQVIA Clinical Technologies develops and delivers clinical trial software products providing sponsors, sites, and CROs with an operational advantage to transform the trial experience for sites and patients. We apply our expertise in health care grade AI to gain efficiencies and insights in trial planning and budgeting, sponsorsite communication, patient engagement, and sponsor oversight. Our market-leading SaaS products and tech enabled services are offered independently from our CRO services to match any business model. Explore our full line of orchestrated clinical trial technologies at iqvia.com/oct and contact us to learn more.

Further Information

Interested in attending this virtual roundtable or running your own? Drop us a message today and we will get in touch

Here To Help

Need help registering your team? Just get in touch and a member of the team will be happy to help.

[contact-form-7]

The post IQVIA – Innovation Day at Scope Europe 2024 appeared first on Proventa International.

IQVIA Clinical Technology Impact Dinner 2024

Bryan — Thu, 18 Apr 2024 14:47:36 +0000

16
May

06:30 PM CEST

IQVIA Strategy Dinner 2024

Season 52, 3535 US-1 Suite 100B Princeton, NJ 08540

FULLY BOOKED

What to expect

Timely information, interactive format

Join us for dinner, drinks and discussions on how technology is shaping the future of clinical trials.

While IQVIA is the world’s leading CRO, IQVIA also offers a breadth of technologies for sponsors, sites, patients and even other CROs to use in their trials.

Engage in conversation with peers and IQVIA technology experts in understanding how technology is impacting clinical operations. Hear of recent research results highlighting what your peers are doing with technology and how it is helping drive new levels of efficiency.

IQVIA Technologies. Hear the vision. Join the Journey.

Our Agenda

Why you should attend

Meet Our Facilitator

Kevin Landells

Vice President, Business Head for IRT IQVIA Technologies

Jim DiCesare

Vice President, Financial Management Solutions IQVIA Technologies

KK Rumrill

Senior Director, Site Suite IQVIA Technologies

Naouel Baili

Director, AI Scientist IQVIA Technologies

First name	Last name	Job title	Company name	Photo URL	Bio Position
Kevin Landells		Vice President, Business Head for IRT	IQVIA Technologies	https://proventainternational.com/wp-content/uploads/2023/08/Kevin-Landells.jpg	Kevin has over 25 years of experience in the IRT/ RTSM industry, having worked across many technical and project management leadership roles. Experienced with developing and leading global teams delivering managed services spanning operations, project management, client partnerships and Business transformation. Kevin is passionate about improving healthcare and utilizing technology that makes a real difference to patients’ lives. Kevin holds a Bachelors’ Degree in Computer Science from Hertfordshire University in the UK.
Jim	DiCesare	Vice President, Financial Management Solutions	IQVIA Technologies	https://proventainternational.com/wp-content/uploads/2024/02/James-DiCesare.jpg	Jim DiCesare is passionate about delivering innovative Cost Benchmarking, CTA Negotiation and Site Payment services that support clinical research conducted by sponsors and CROs. With over 25 years of industry experience leading clinical operations teams at Merck, DrugDev, and now IQVIA Technologies, Jim has expertise across the contracting, budgeting, and investigator grant payment management continuum. He is a frequent speaker at industry conferences and has written for a variety of publications. He has a B.S. in Accounting from Kutztown University.
KK	Rumrill	Senior Director, Site Suite	IQVIA Technologies	https://proventainternational.com/wp-content/uploads/2024/02/KK-Rumrill.jpg	KK Rumrill has more than 25 years’ experience in product development, customer support, and implementation services teams in clinical trials. She was a key leader in client operations at BBK Worldwide, driving growth in global patient recruitment, site engagement, and trial optimization. In 2013, KK moved to TrialNetworks, which was acquired by DrugDev and subsequently by IQVIA in 2017. She now leads several key product teams in IQVIA Technologies’ Orchestrated Clinical Trials platform.
Naouel	Baili	Director, AI Scientist	IQVIA Technologies	https://proventainternational.com/wp-content/uploads/2024/04/Naouel-Baili.jpg	Naouel is an expert in emerging technology solutions, leveraging over ten years of experience in the life sciences industry to transform clinical trial management. Her proficiency in embedding sophisticated AI tools into SaaS platforms has significantly improved both user experience and operational efficiency. A holder of a Ph.D. in Computer Science, she excels in the development and design of innovative AI capabilities that streamline and optimize clinical research.

Kevin Landells, Jim DiCesare, KK Rumrill, Naouel Baili

More about IQVIA

More information

IQVIA Clinical Technologies develops and delivers clinical trial software products providing sponsors, sites, and CROs with an operational advantage to transform the trial experience for sites and patients. We apply our expertise in health care grade AI to gain efficiencies and insights in trial planning and budgeting, sponsorsite communication, patient engagement, and sponsor oversight. Our market-leading SaaS products and tech enabled services are offered independently from our CRO services to match any business model. Explore our full line of orchestrated clinical trial technologies at iqvia.com/oct and contact us to learn more.

Further Information

Interested in attending this virtual roundtable or running your own? Drop us a message today and we will get in touch

Here To Help

Need help registering your team? Just get in touch and a member of the team will be happy to help.

[contact-form-7]

The post IQVIA Clinical Technology Impact Dinner 2024 appeared first on Proventa International.

IQVIA Technologies – Clinical Technologies Innovation Day 2024

Bryan — Mon, 01 Apr 2024 15:55:48 +0000

15
May

IQVIA Clinical Technologies Innovation Day 2024

Princeton Marriott at Forrestal, Princeton, New Jersey

What to expect

Timely information, interactive format

Join IQVIA Technologies digital product leaders, customer success experts, and industry leaders for an afternoon of discussions, demos, and networking. We’ll share our vision to transform clinical operations, the progress we’ve made to date, and our roadmap for 2024 and beyond.

Our Agenda

Kevin Landells, VP, Business Head for IRT, IQVIA Technologies

Murray Aitken
Executive Director
IQVIA Institute

MODERATOR
Murray Aitken
Executive Director
IQVIA Institute

PANELIST
Jane Twitchen, Executive Director, Head of Clinical Trial Accelerator Unit, Global Clinical Operations, Biogen
Rick O’Hara, Director, Clinical Outsourcing, OncoC4
Ann Dokus, Senior Director, Site & Patient Networks, IQVIA
Karri Venn, VP Site Advocacy & Mentorship, SCRS

MODERATOR:
Kevin Landells, VP, Business Head for IRT, IQVIA Technologies

PANELISTS:
Zabir Macci, Director, eCOA Business Strategy,IQVIA Technologies
Tim Riely, Vice President, Clinical Data & Analytics, IQVIA Technologies
Jim DiCesare, Vice President, Financial Management Solutions, IQVIA Technologies
KK Rumrill, Senior Director, Site Suite, IQVIA Technologies

MODERATOR:
Kevin Landells, VP, Business Head for IRT, IQVIA Technologies

Why you should attend

Decision- makers from Clinical Operations, Data Analytics and AI, Digital Health, Clinical Innovation, Clinical Technology, Clinical Supply Chain, Clinical Finance, Clinical Budgets and Payments, Grants and Contracts, Clinical Outsourcing, Trial Optimization, Business Operations, Study Start-Up, Trial Management functions should attend.

Meet Our Speakers

Kevin Landells

Vice President, Business Head for IRT IQVIA Technologies

Tim Riely

Vice President, Clinical Data & Analytics IQVIA

KK Rumrill

Senior Director, Site Suite IQVIA Technologies

Jim DiCesare

Vice President, Financial Management Solutions IQVIA Technologies

Ann Dokus

Senior Director, Experience Optimization Patient Centric Solutions and Decentralized Trials IQVIA

Ann Dokus is the Senior Director of Experience Optimization in the Patient and Site Centric Solutions organization. An industry veteran of with over 30 years experience in Pharmaceutical R&D, Medical Devices, Information Technology and Clinical Research, Ann’s journey has spanned start ups, Fortune 100 companies and ultimately a role at IQVIA.
Ann is a passionate advocate for Patients, firmly believing in delivering clinical research opportunities to the community. She has spearheaded technology initiatives in Identity and Access Management, Clinical Trial Matching, Patient Recruitment, Medical Records Retrieval and is now excited about the power of Artificial Intelligence to deliver accessibility to trials. A firm believer in meeting the patients where they are, Ann’s focus at IQVIA is supporting sponsors and sites in delivering the promise of the “last mile” … enrolled, supported and sustained patient engagement while optimizing the patient experience throughout the journey.

Murray Aitken

Executive Director, Senior Vice President IQVIA Institute for Human Data Science, IQVIA

Jane Twitchen

Executive Director, Head, Clinical Trial Accelerator Unit Biogen

Jane Twitchen graduated with a BSc in Medical Physics from the University of Exeter, UK and commenced her career with Covance, supporting a number of trials investigating radioisotope image optimisation. Having developed a keen interest in processes and systems, she then joined SAS, where she worked in the Alliances team collaborating with partners such as PWC, McKinsey and Accenture to define and implement solutions for pharmaceutical clients. During her tenure with SAS, Jane was also sponsored to complete her MBA. She proceeded to a number of software and service providers prior to joining Biogen in 2013, initially joining the Global Regulatory Affairs Quality and Operations team and moving to Global Clinical Operations in 2015. In her current role, Jane is Executive Director, Head of Biogen’s Clinical Trial Accelerator Unit and is responsible for delivery of Biogen’s goals for accelerated study start-up cycle time, in addition to embedding innovative operational delivery through the use of technology.

Zabir Macci

Director, eCOA Business Strategy IQVIA

Rick O’Hara

Director, Clinical Outsourcing OncoC4

Karri Venn

VP, Site Advocacy & Mentorship Society for Clinical Research Sites

Karri Venn brings over 25 years of clinical research experience working at clinical research sites. The ride has been monumental both in personal and professional growth. Ms. Venn started her career at LMC Healthcare in 1999 and that progressed to LMC Manna Research and ended with Centricity Research. A wide variety of positions Ms. Venn has held throughout the years in this wonderful organization and focused much of her role as a leader in operations growing the Canadian enterprise to one of the most successful integrated research organizations (IROs) in Canada. Always at the center of attention, was the importance to provide better healthcare to patients and has utilized the research experience as one way to achieve this goal. In maintaining this mission, Karri Venn has opened her own independent consulting company to further provide support to various organizations ie. Sponsor/CRO, Clinical Research Sites, Private Equity and is presently VP, Site Advocacy & Mentorship for SCRS (Society for Clinical Research Sites). Responsibilities throughout her tenure has included the successful openings of 13 LMC Healthcare clinics across Canada, including Canada’s only Diabetes Clinical Research Unit and establishing the largest Canadian non-academic Endocrinology Research program. The merger and integration of various primary care and specialty clinical research sites to form one of the largest IROs in Canada. True North Research, Aventiv and IACT Health integrated with LMC Manna Research to form Centricity Research growing to more than 30 sites with expertise in all phases and majority of therapeutic areas. Additional responsibilities included acting as CEO for hyperCORE International a super network of elite sites coming together to share best practices and continue to push research excellence. Many distinctions and awards along the way include but not limited to: SPRIA, Centers of Excellence and Top 50 Great Places to Work for Canada. Ms. Venn has been certified in project management through the Project Management Institute, as well as longstanding certification as a Clinical Research Coordinator by ACRP. The importance of giving back and to share the site voice continues through her various consulting and strategic partnerships in the industry – most notably acting as chair of for the global committee of Society for Clinical Research Sites (SCRS).

First name	Last name	Job title	Company name	Photo URL	Bio Position
Kevin Landells		Vice President, Business Head for IRT	IQVIA Technologies	https://proventainternational.com/wp-content/uploads/2023/08/Kevin-Landells.jpg	Kevin has over 25 years of experience in the IRT/ RTSM industry, having worked across many technical and project management leadership roles. Experienced with developing and leading global teams delivering managed services spanning operations, project management, client partnerships and Business transformation. Kevin is passionate about improving healthcare and utilizing technology that makes a real difference to patients’ lives. Kevin holds a Bachelors’ Degree in Computer Science from Hertfordshire University in the UK.
Tim Riely		Vice President, Clinical Data & Analytics	IQVIA	https://proventainternational.com/wp-content/uploads/2023/08/Tim-Riely-1.jpg	Tim has 20 years of experience delivering business intelligence, data management and analytical solutions in both leadership and consulting roles. Tim currently leads the IQIVA Clinical Data Analytics Suite (CDAS), providing both SaaS solutions for the market as well as IQVIA’s internal CRO needs. As head of CDAS, Tim is responsible for full lifecycle delivery of R&D data and visualizations solutions for clinical operations, clinical data management, and analytics-as-service products. Tim’s background includes a unique combination of payer, provider, and clinical research technology experience.
KK	Rumrill	Senior Director, Site Suite	IQVIA Technologies	https://proventainternational.com/wp-content/uploads/2024/02/KK-Rumrill.jpg	KK Rumrill has more than 25 years’ experience in product development, customer support, and implementation services teams in clinical trials. She was a key leader in client operations at BBK Worldwide, driving growth in global patient recruitment, site engagement, and trial optimization. In 2013, KK moved to TrialNetworks, which was acquired by DrugDev and subsequently by IQVIA in 2017. She now leads several key product teams in IQVIA Technologies’ Orchestrated Clinical Trials platform.
Jim	DiCesare	Vice President, Financial Management Solutions	IQVIA Technologies	https://proventainternational.com/wp-content/uploads/2024/02/James-DiCesare.jpg	Jim DiCesare is passionate about delivering innovative Cost Benchmarking, CTA Negotiation and Site Payment services that support clinical research conducted by sponsors and CROs. With over 25 years of industry experience leading clinical operations teams at Merck, DrugDev, and now IQVIA Technologies, Jim has expertise across the contracting, budgeting, and investigator grant payment management continuum. He is a frequent speaker at industry conferences and has written for a variety of publications. He has a B.S. in Accounting from Kutztown University.
Ann	Dokus	Senior Director, Experience Optimization Patient Centric Solutions and Decentralized Trials	IQVIA	https://proventainternational.com/wp-content/uploads/2022/12/Ann-Dokus.jpg	Ann Dokus is the Senior Director of Experience Optimization in the Patient and Site Centric Solutions organization. An industry veteran of with over 30 years experience in Pharmaceutical R&D, Medical Devices, Information Technology and Clinical Research, Ann’s journey has spanned start ups, Fortune 100 companies and ultimately a role at IQVIA. Ann is a passionate advocate for Patients, firmly believing in delivering clinical research opportunities to the community. She has spearheaded technology initiatives in Identity and Access Management, Clinical Trial Matching, Patient Recruitment, Medical Records Retrieval and is now excited about the power of Artificial Intelligence to deliver accessibility to trials. A firm believer in meeting the patients where they are, Ann’s focus at IQVIA is supporting sponsors and sites in delivering the promise of the “last mile” … enrolled, supported and sustained patient engagement while optimizing the patient experience throughout the journey.
Murray	Aitken	Executive Director, Senior Vice President	IQVIA Institute for Human Data Science, IQVIA	https://proventainternational.com/wp-content/uploads/2024/02/Murray-Aitken.jpg	As head of the IQVIA Institute for Human Data Science, Murray Aitken provides policy setters and decision-makers in the global health sector with evidence, analysis, and insights that contribute to the advancement of Human Data Science to improve human health outcomes. Aitken is tasked with creating and managing a research agenda that leaders in global governments, payers, providers, academia, and the life sciences industry use to accelerate the understanding of global trends in disease patterns, data science, and technology. This research is used to foster innovation critical to evidence-based decision-making and the advancement of human health.
Jane	Twitchen	Executive Director, Head, Clinical Trial Accelerator Unit	Biogen	https://proventainternational.com/wp-content/uploads/2022/03/Jane-Twitchen.jpg	Jane Twitchen graduated with a BSc in Medical Physics from the University of Exeter, UK and commenced her career with Covance, supporting a number of trials investigating radioisotope image optimisation. Having developed a keen interest in processes and systems, she then joined SAS, where she worked in the Alliances team collaborating with partners such as PWC, McKinsey and Accenture to define and implement solutions for pharmaceutical clients. During her tenure with SAS, Jane was also sponsored to complete her MBA. She proceeded to a number of software and service providers prior to joining Biogen in 2013, initially joining the Global Regulatory Affairs Quality and Operations team and moving to Global Clinical Operations in 2015. In her current role, Jane is Executive Director, Head of Biogen’s Clinical Trial Accelerator Unit and is responsible for delivery of Biogen’s goals for accelerated study start-up cycle time, in addition to embedding innovative operational delivery through the use of technology.
Zabir	Macci	Director, eCOA Business Strategy	IQVIA	https://proventainternational.com/wp-content/uploads/2020/10/Zabir-Macci_2019-sm.jpg	Zabir brings over 15 years of learning across risk-based and centralized monitoring, eCOA, business analysis, clinical technologies, process improvement, and analytics for clinical trials. He is part of IQVIA’s DP&S (Digital Products and Solutions) team involved in the development and execution of business strategies working closely with the cross-functional leadership teams to influence strategic priorities and ensure it exceeds customer expectations and market demands. He holds a Bachelor of Engineering degree in Computer Science from India and has an MBA in Management and Marketing from Texas Tech University.
Rick	O’Hara	Director, Clinical Outsourcing	OncoC4	https://proventainternational.com/wp-content/uploads/2024/04/Rick-OHara.jpg	Rick O’Hara has been working in the R&D/Clinical business operations arena for over 25 years. Operating in all facets of outsourcing at OncoC4, Endo and Johnson and Johnson. He holds a BS and an MBA from St. Josehp’s University in Philadelphia
Karri	Venn	VP, Site Advocacy & Mentorship	Society for Clinical Research Sites	https://proventainternational.com/wp-content/uploads/2024/04/karri-venn.jpg	Karri Venn brings over 25 years of clinical research experience working at clinical research sites. The ride has been monumental both in personal and professional growth. Ms. Venn started her career at LMC Healthcare in 1999 and that progressed to LMC Manna Research and ended with Centricity Research. A wide variety of positions Ms. Venn has held throughout the years in this wonderful organization and focused much of her role as a leader in operations growing the Canadian enterprise to one of the most successful integrated research organizations (IROs) in Canada. Always at the center of attention, was the importance to provide better healthcare to patients and has utilized the research experience as one way to achieve this goal. In maintaining this mission, Karri Venn has opened her own independent consulting company to further provide support to various organizations ie. Sponsor/CRO, Clinical Research Sites, Private Equity and is presently VP, Site Advocacy & Mentorship for SCRS (Society for Clinical Research Sites). Responsibilities throughout her tenure has included the successful openings of 13 LMC Healthcare clinics across Canada, including Canada’s only Diabetes Clinical Research Unit and establishing the largest Canadian non-academic Endocrinology Research program. The merger and integration of various primary care and specialty clinical research sites to form one of the largest IROs in Canada. True North Research, Aventiv and IACT Health integrated with LMC Manna Research to form Centricity Research growing to more than 30 sites with expertise in all phases and majority of therapeutic areas. Additional responsibilities included acting as CEO for hyperCORE International a super network of elite sites coming together to share best practices and continue to push research excellence. Many distinctions and awards along the way include but not limited to: SPRIA, Centers of Excellence and Top 50 Great Places to Work for Canada. Ms. Venn has been certified in project management through the Project Management Institute, as well as longstanding certification as a Clinical Research Coordinator by ACRP. The importance of giving back and to share the site voice continues through her various consulting and strategic partnerships in the industry – most notably acting as chair of for the global committee of Society for Clinical Research Sites (SCRS).

Kevin Landells, Tim Riely, KK Rumrill, Jim DiCesare, Ann Dokus, Murray Aitken, Jane Twitchen, Zabir Macci, Rick O’Hara, Karri Venn

Register Now

As the event is hosted in person, attendance is limited. We want to make sure your experience with us is relevant. Therefore, we will confirm each registered guest individually. Please check your inbox for the confirmation email.

[contact-form-7]

Hotel u0026 Venue

PRINCETON MARRIOTT AT FORRESTAL

Nestled on 25 wooded acres and conveniently located near downtown, Princeton Marriott at Forrestal is an upscale hotel in Princeton, NJ, with resort-style accommodations.

Hotel Details Maps & Direction Parking

More about IQVIA

More information

IQVIA Clinical Technologies develops and delivers clinical trial software products providing sponsors, sites, and CROs with an operational advantage to transform the trial experience for sites and patients. We apply our expertise in healthcare-grade AI to gain efficiencies and insights in trial planning and budgeting, sponsor-site communication, patient engagement, and sponsor oversight. Our market-leading SaaS products and tech-enabled services are offered independently from our CRO services to match any business model. Explore our full line of orchestrated clinical trial technologies at iqvia.com/oct and contact us to learn more.

If you want to
know more

Here To Help

Need help registering your team? Just get in touch and a member of the team will be happy to help.

[contact-form-7]

The post IQVIA Technologies – Clinical Technologies Innovation Day 2024 appeared first on Proventa International.

IQVIA Technologies – Clinical Technologies Innovation Day 2024

Bryan — Thu, 22 Feb 2024 20:23:43 +0000

15
May

IQVIA Clinical Technologies Innovation Day 2024

Princeton Marriott at Forrestal, Princeton, New Jersey

What to expect

Timely information, interactive format

Our Agenda

Kevin Landells, VP, Business Head for IRT, IQVIA Technologies

Murray Aitken
Executive Director
IQVIA Institute

MODERATOR
Murray Aitken
Executive Director
IQVIA Institute

MODERATOR:
Kevin Landells, VP, Business Head for IRT, IQVIA Technologies

Why you should attend

Meet Our Speakers

Kevin Landells

Vice President, Business Head for IRT IQVIA Technologies

Tim Riely

Vice President, Clinical Data & Analytics IQVIA

KK Rumrill

Senior Director, Site Suite IQVIA Technologies

Jim DiCesare

Vice President, Financial Management Solutions IQVIA Technologies

Ann Dokus

Senior Director, Experience Optimization Patient Centric Solutions and Decentralized Trials IQVIA

Murray Aitken

Executive Director, Senior Vice President IQVIA Institute for Human Data Science, IQVIA

Jane Twitchen

Executive Director, Head, Clinical Trial Accelerator Unit Biogen

Zabir Macci

Director, eCOA Business Strategy IQVIA

Rick O’Hara

Director, Clinical Outsourcing OncoC4

Karri Venn

VP, Site Advocacy & Mentorship Society for Clinical Research Sites

First name	Last name	Job title	Company name	Photo URL	Bio Position
Kevin Landells		Vice President, Business Head for IRT	IQVIA Technologies	https://proventainternational.com/wp-content/uploads/2023/08/Kevin-Landells.jpg	Kevin has over 25 years of experience in the IRT/ RTSM industry, having worked across many technical and project management leadership roles. Experienced with developing and leading global teams delivering managed services spanning operations, project management, client partnerships and Business transformation. Kevin is passionate about improving healthcare and utilizing technology that makes a real difference to patients’ lives. Kevin holds a Bachelors’ Degree in Computer Science from Hertfordshire University in the UK.
Tim Riely		Vice President, Clinical Data & Analytics	IQVIA	https://proventainternational.com/wp-content/uploads/2023/08/Tim-Riely-1.jpg	Tim has 20 years of experience delivering business intelligence, data management and analytical solutions in both leadership and consulting roles. Tim currently leads the IQIVA Clinical Data Analytics Suite (CDAS), providing both SaaS solutions for the market as well as IQVIA’s internal CRO needs. As head of CDAS, Tim is responsible for full lifecycle delivery of R&D data and visualizations solutions for clinical operations, clinical data management, and analytics-as-service products. Tim’s background includes a unique combination of payer, provider, and clinical research technology experience.
KK	Rumrill	Senior Director, Site Suite	IQVIA Technologies	https://proventainternational.com/wp-content/uploads/2024/02/KK-Rumrill.jpg	KK Rumrill has more than 25 years’ experience in product development, customer support, and implementation services teams in clinical trials. She was a key leader in client operations at BBK Worldwide, driving growth in global patient recruitment, site engagement, and trial optimization. In 2013, KK moved to TrialNetworks, which was acquired by DrugDev and subsequently by IQVIA in 2017. She now leads several key product teams in IQVIA Technologies’ Orchestrated Clinical Trials platform.
Jim	DiCesare	Vice President, Financial Management Solutions	IQVIA Technologies	https://proventainternational.com/wp-content/uploads/2024/02/James-DiCesare.jpg	Jim DiCesare is passionate about delivering innovative Cost Benchmarking, CTA Negotiation and Site Payment services that support clinical research conducted by sponsors and CROs. With over 25 years of industry experience leading clinical operations teams at Merck, DrugDev, and now IQVIA Technologies, Jim has expertise across the contracting, budgeting, and investigator grant payment management continuum. He is a frequent speaker at industry conferences and has written for a variety of publications. He has a B.S. in Accounting from Kutztown University.
Ann	Dokus	Senior Director, Experience Optimization Patient Centric Solutions and Decentralized Trials	IQVIA	https://proventainternational.com/wp-content/uploads/2022/12/Ann-Dokus.jpg	Ann Dokus is the Senior Director of Experience Optimization in the Patient and Site Centric Solutions organization. An industry veteran of with over 30 years experience in Pharmaceutical R&D, Medical Devices, Information Technology and Clinical Research, Ann’s journey has spanned start ups, Fortune 100 companies and ultimately a role at IQVIA. Ann is a passionate advocate for Patients, firmly believing in delivering clinical research opportunities to the community. She has spearheaded technology initiatives in Identity and Access Management, Clinical Trial Matching, Patient Recruitment, Medical Records Retrieval and is now excited about the power of Artificial Intelligence to deliver accessibility to trials. A firm believer in meeting the patients where they are, Ann’s focus at IQVIA is supporting sponsors and sites in delivering the promise of the “last mile” … enrolled, supported and sustained patient engagement while optimizing the patient experience throughout the journey.
Murray	Aitken	Executive Director, Senior Vice President	IQVIA Institute for Human Data Science, IQVIA	https://proventainternational.com/wp-content/uploads/2024/02/Murray-Aitken.jpg	As head of the IQVIA Institute for Human Data Science, Murray Aitken provides policy setters and decision-makers in the global health sector with evidence, analysis, and insights that contribute to the advancement of Human Data Science to improve human health outcomes. Aitken is tasked with creating and managing a research agenda that leaders in global governments, payers, providers, academia, and the life sciences industry use to accelerate the understanding of global trends in disease patterns, data science, and technology. This research is used to foster innovation critical to evidence-based decision-making and the advancement of human health.
Jane	Twitchen	Executive Director, Head, Clinical Trial Accelerator Unit	Biogen	https://proventainternational.com/wp-content/uploads/2022/03/Jane-Twitchen.jpg	Jane Twitchen graduated with a BSc in Medical Physics from the University of Exeter, UK and commenced her career with Covance, supporting a number of trials investigating radioisotope image optimisation. Having developed a keen interest in processes and systems, she then joined SAS, where she worked in the Alliances team collaborating with partners such as PWC, McKinsey and Accenture to define and implement solutions for pharmaceutical clients. During her tenure with SAS, Jane was also sponsored to complete her MBA. She proceeded to a number of software and service providers prior to joining Biogen in 2013, initially joining the Global Regulatory Affairs Quality and Operations team and moving to Global Clinical Operations in 2015. In her current role, Jane is Executive Director, Head of Biogen’s Clinical Trial Accelerator Unit and is responsible for delivery of Biogen’s goals for accelerated study start-up cycle time, in addition to embedding innovative operational delivery through the use of technology.
Zabir	Macci	Director, eCOA Business Strategy	IQVIA	https://proventainternational.com/wp-content/uploads/2020/10/Zabir-Macci_2019-sm.jpg	Zabir brings over 15 years of learning across risk-based and centralized monitoring, eCOA, business analysis, clinical technologies, process improvement, and analytics for clinical trials. He is part of IQVIA’s DP&S (Digital Products and Solutions) team involved in the development and execution of business strategies working closely with the cross-functional leadership teams to influence strategic priorities and ensure it exceeds customer expectations and market demands. He holds a Bachelor of Engineering degree in Computer Science from India and has an MBA in Management and Marketing from Texas Tech University.
Rick	O’Hara	Director, Clinical Outsourcing	OncoC4	https://proventainternational.com/wp-content/uploads/2024/04/Rick-OHara.jpg	Rick O’Hara has been working in the R&D/Clinical business operations arena for over 25 years. Operating in all facets of outsourcing at OncoC4, Endo and Johnson and Johnson. He holds a BS and an MBA from St. Josehp’s University in Philadelphia
Karri	Venn	VP, Site Advocacy & Mentorship	Society for Clinical Research Sites	https://proventainternational.com/wp-content/uploads/2024/04/karri-venn.jpg	Karri Venn brings over 25 years of clinical research experience working at clinical research sites. The ride has been monumental both in personal and professional growth. Ms. Venn started her career at LMC Healthcare in 1999 and that progressed to LMC Manna Research and ended with Centricity Research. A wide variety of positions Ms. Venn has held throughout the years in this wonderful organization and focused much of her role as a leader in operations growing the Canadian enterprise to one of the most successful integrated research organizations (IROs) in Canada. Always at the center of attention, was the importance to provide better healthcare to patients and has utilized the research experience as one way to achieve this goal. In maintaining this mission, Karri Venn has opened her own independent consulting company to further provide support to various organizations ie. Sponsor/CRO, Clinical Research Sites, Private Equity and is presently VP, Site Advocacy & Mentorship for SCRS (Society for Clinical Research Sites). Responsibilities throughout her tenure has included the successful openings of 13 LMC Healthcare clinics across Canada, including Canada’s only Diabetes Clinical Research Unit and establishing the largest Canadian non-academic Endocrinology Research program. The merger and integration of various primary care and specialty clinical research sites to form one of the largest IROs in Canada. True North Research, Aventiv and IACT Health integrated with LMC Manna Research to form Centricity Research growing to more than 30 sites with expertise in all phases and majority of therapeutic areas. Additional responsibilities included acting as CEO for hyperCORE International a super network of elite sites coming together to share best practices and continue to push research excellence. Many distinctions and awards along the way include but not limited to: SPRIA, Centers of Excellence and Top 50 Great Places to Work for Canada. Ms. Venn has been certified in project management through the Project Management Institute, as well as longstanding certification as a Clinical Research Coordinator by ACRP. The importance of giving back and to share the site voice continues through her various consulting and strategic partnerships in the industry – most notably acting as chair of for the global committee of Society for Clinical Research Sites (SCRS).

Kevin Landells, Tim Riely, KK Rumrill, Jim DiCesare, Ann Dokus, Murray Aitken, Jane Twitchen, Zabir Macci, Rick O’Hara, Karri Venn

Register Now

[contact-form-7]

Hotel & Venue

PRINCETON MARRIOTT AT FORRESTAL

Nestled on 25 wooded acres and conveniently located near downtown, Princeton Marriott at Forrestal is an upscale hotel in Princeton, NJ, with resort-style accommodations.

Hotel Details Maps & Direction Parking

More about IQVIA

More information

IQVIA Technologies(NYSE:IQV) is a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry. IQVIA creates intelligent connections to deliver powerful insights with speed and agility — enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 82,000 employees, IQVIA conducts operations in more than 100 countries. Learn more at www.iqvia.com/oct

If you want to
know more

Here To Help

Need help registering your team? Just get in touch and a member of the team will be happy to help.

[contact-form-7]

The post IQVIA Technologies – Clinical Technologies Innovation Day 2024 appeared first on Proventa International.

IQVIA Innovate 2023: Global Drug Safety Conference

Bryan — Wed, 25 Oct 2023 20:55:33 +0000

14 -16
November

IQVIA Innovate 2023: Global Drug Safety Conference

Hilton Barcelona – Avenida Diagonal 589-591 Barcelona, 08014

What to expect

Timely information, interactive format

IQVIA Innovate is the must attend Global Drug Safety Conference with agenda topics and discussions centered around how your organization can benefit from enhancing your processes and data with technology.

Through thought-provoking live sessions, hands-on demos, and networking opportunities, IQVIA Innovate 2023 will provide companies an invaluable showcase of the proof points and benefits that accrue when organizations evolve to achieve their ambitions.

Our Agenda

7:30 AM CET – Registration
8:00 AM CET – Breakfast | Learning Zone Open
9:00 AM CET – Welcome and Introduction to the Event
9:15 AM CET – The Changing World of Safety
9:45 AM CET – Meeting the challenges of change
–Updesh Dosanjh
Practice Leader, IQVIA Technology Solutions
IQVIA
10:15 AM CET – Client Case Study
11:00 AM CET – Coffee Break
11:15 AM CET – Regulation update and how they will impact Safety
–Uwe Trinks
Practice Leader PV & RM Services
IQVIA
12:00 AM CET – Lunch, Networking and Learning Zone Open
1:00 PM CET – Client Case Study: How Sandoz are using a new technology to enhance legacy systems and support an in…
–Sandoz Speaker
Sandoz
1:45 PM CET – The opportunities and threats of Generative AI such as ChatGPT and Deepmind
–Uwe Trinks
Practice Leader PV & RM Services
IQVIA
2:30 PM CET – Coffee Break and Networking
3:00 PM CET – Automation for integrating your call center into your safety systems
–Axel Hagel
Practice Leader, PV & RM Services
IQVIA
3:30 PM CET – QPPV role evolution and how technology can help: PANEL
4:00 PM CET – Industry Survey Feedback
–Scott Fonesca
Global Head of Sales Pharmacovigilance and Regulatory Technology Solutions
IQVIA
–Updesh Dosanjh
Practice Leader, IQVIA Technology Solutions
IQVIA
4:45 PM CET – Day 1 Closing Remarks

5:00 PM CET – Learning Zone Open
7:30 PM CET – Off-Site Dinner

7:30 AM CET – Registration
8:00 AM CET – Breakfast | Learning Zone Open
9:00 AM CET – Introducing Day 2
9:15 AM CET – Bringing Safety, Regulatory and Quality together to drive innovation
–Joe Rymsza
VP, Safety, Regulatory and Quality
IQVIA
9:45 AM CET – How CROs are using technology to drive efficiency and manage industry’s evolution
10:30 AM CET – Coffee Break
10:45 AM CET – User friendly Data Analytics
11:45 AM CET – Walkthrough the afternoon
11:55 AM CET – Lunch, Networking and Learning Zone Open
1:00 PM CET – New product features and directions for Oracle’s Argus database.
–Axel Hagel
Practice Leader, PV & RM Services
IQVIA
Bringing your data together
–Scott Fonesca
Global Head of Sales Pharmacovigilance and Regulatory Technology Solutions
IQVIA
1:45 PM CET – Client Case Study: Extending the functionality of Argus
Finding Adverse Events in unstructured data
–Marie Flanagan
Director, Offering Management
IQVIA Vigilance Detec
2:30 PM CET – Coffee Break and Networking
3:00 PM CET – Panel: Where next for your Safety System
–Axel Hagel
Practice Leader, PV & RM Services
IQVIA
– Using Real World Evidence in Signal Detection
3:45 PM CET – Closing Remarks

Why you should attend

The conference will include thought provoking roundtable sessions on the hottest topics in the industry, time to network with your peers, and a variety of other timely pharmacovigilance sessions, such as:
-The opportunities and risk of Generative AI such as ChatGPT and Deepmind
-How CROs are using technology to drive efficiency and manage industry’s evolution
-Using a broad range of data such as Real-World Evidence in Signal Detection
-How Safety Systems and Technology are adopting new capabilities
-What companies are doing to be successful with new technology

Meet Our Facilitator

Updesh Dosanjh

Practice Leader, Technology Solutions IQVIA

Session – Automation and AI in Action: Accelerating PV with Innovations in Intake
As Practice Leader for the Technology Solutions business unit of IQVIA, Updesh Dosanjh is responsible developing the overarching strategy regarding Artificial Intelligence and Machine Learning as it relates to safety and pharmacovigilance. He is focused on the adoption of these innovative technologies and processes that will help optimize pharmacovigilance activities for better, faster results. 
Dosanjh has over 25 years of knowledge and experience in the management, development, implementation, and operation of processes and systems within the life sciences and other industries. 
Most recently, Dosanjh was with Foresight and joined IQVIA as a result of an acquisition. Over the course of his career, Dosanjh also worked with WCI, Logistics Consulting Partners, Amersys Systems Limited and FJ Systems. Dosanjh holds a Bachelor’s degree in Materials Science from Manchester University and a Master’s degree in Advanced Manufacturing Systems and Technology from Liverpool University

Marie Flanagan

Director, Offering Management IQVIA Vigilance Detect

Scott Fonesca

Global Head of Sales Pharmacovigilance and Regulatory Technology Solutions IQVIA

Axel Hagel

Practice Leader, PV & RM Services IQVIA

Uwe Trinks

Practice Leader PV & RM Services IQVIA

First name	Last name	Job title	Company name	Photo URL	Bio Position
Updesh	Dosanjh	Practice Leader, Technology Solutions	IQVIA	https://proventainternational.com/wp-content/uploads/2020/06/UpdeshDosanjh-headshot-2020-e1591888430290.jpg	Session – Automation and AI in Action: Accelerating PV with Innovations in Intake As Practice Leader for the Technology Solutions business unit of IQVIA, Updesh Dosanjh is responsible developing the overarching strategy regarding Artificial Intelligence and Machine Learning as it relates to safety and pharmacovigilance. He is focused on the adoption of these innovative technologies and processes that will help optimize pharmacovigilance activities for better, faster results. Dosanjh has over 25 years of knowledge and experience in the management, development, implementation, and operation of processes and systems within the life sciences and other industries. Most recently, Dosanjh was with Foresight and joined IQVIA as a result of an acquisition. Over the course of his career, Dosanjh also worked with WCI, Logistics Consulting Partners, Amersys Systems Limited and FJ Systems. Dosanjh holds a Bachelor’s degree in Materials Science from Manchester University and a Master’s degree in Advanced Manufacturing Systems and Technology from Liverpool University
Marie Flanagan		Director, Offering Management	IQVIA Vigilance Detect	https://proventainternational.com/wp-content/uploads/2023/10/Marie-Flanagan.jpg
Scott Fonesca		Global Head of Sales Pharmacovigilance and Regulatory Technology Solutions	IQVIA	https://proventainternational.com/wp-content/uploads/2023/10/Scott-Fonesca.jpg
Axel Hagel		Practice Leader, PV & RM Services	IQVIA	https://proventainternational.com/wp-content/uploads/2023/10/Axel-Hagel.jpg
Uwe Trinks		Practice Leader PV & RM Services	IQVIA	https://proventainternational.com/wp-content/uploads/2023/10/Uwe-Trinks.jpg

Updesh Dosanjh, Marie Flanagan, Scott Fonesca, Axel Hagel, Uwe Trinks

Register Now

[contact-form-7]

More about IQVIA

More information

IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry. IQVIA creates intelligent connections to deliver powerful insights with speed and agility — enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 82,000 employees, IQVIA conducts operations in more than 100 countries. Learn more at www.iqvia.com

Further Information

Interested in attending this virtual roundtable or running your own? Drop us a message today and we will get in touch

Here To Help

Need help registering your team? Just get in touch and a member of the team will be happy to help.

[contact-form-7]

The post IQVIA Innovate 2023: Global Drug Safety Conference appeared first on Proventa International.

Clinical Trials Archives - Proventa International

Revvity – AI with Purpose: Strategy-First Innovation Across Clinical Trials

AI with Purpose: Strategy-First Innovation Across Clinical Trials

Ocean Prime 140 Seaport Blvd, Boston

Timely information, interactive format

Our Agenda

Registration, Networking & Cocktails

Welcome & Opening Remarks

Roundtable

What Does Oversight Look Like?

Signals Clinical Demo

Roundtable

AI with Purpose Starts with the Patient

Dinner

Closing Remarks & Final Discussion

At this dinner you’ll

Meet Our Facilitators

Amanda Cross

Michelle Fisher

Glenn Guthrie

More about Revvity

Further Information

Here To Help

Revvity – No One Has Enough Data: Building the Federated Ecosystem for Next-Generation Drug Discovery

No One Has Enough Data: Building the Federated Ecosystem for Next-Generation Drug Discovery

STK Steakhouse San Diego

Timely information, interactive format

Our Agenda

Registration, Networking & Cocktails

Welcome & Opening Remarks

Roundtable Discussion

Roundtable Tracks

Dinner

Roundtable

Roundtable Tracks

Coffee & Closing Remarks

Why you should attend

Meet Our Facilitators

David Gosalvez, Ph.D

Gregg Spivey

More about Revvity

Further Information

Here To Help

Revvity – AI with Purpose: Strategy-First Innovation Across Clinical Trials San Francisco 2025

AI with Purpose: Strategy-First Innovation Across Clinical Trials

STK Steakhouse San Francisco

Timely information, interactive format

Our Agenda

Registration, Networking & Cocktails

Welcome & Opening Remarks – Brent Meyers, MBA

Roundtable Discussion

Oversight, AI, and the Future of Clinical Trials

Dinner

Roundtable Discussion

Building a Data-Driven Culture that Accelerates Clinical Trials

Coffee, Cognac & Closing Remarks

Why you should attend

Meet Our Facilitators

Bill Goode, MS

Tonya Arthur

Brent Meyers, MBA

More about Revvity

Further Information

Here To Help

Revvity – AI with Purpose: Strategy-First Innovation Across Drug Discovery 2025

AI with Purpose: Strategy-First Innovation Across Drug Discovery

Boston Chops Downtown

Timely information, interactive format

Our Agenda

Registration, Networking & Cocktails

Welcome & Opening Remarks – David Gosalvez, Revvity

Roundtable Discussion

Solving AI-Driven Discovery at Scale – From Concept to Clinical Candidate

Roundtable

Dinner

Roundtable Tracks

Roundtable

Designing FAIR-Centric Data Platforms for the Future of Multimodal R&D

Coffee, Cognac & Closing Remarks

Why you should attend

No One Has Enough Data: Building the Federated Ecosystem
for Next-Generation Drug Discovery